The NOPAIN for Veterans Act has been reintroduced in the

New Post Public Reply Private Reply Replies (1) Message Board
Chanel5
239
The NOPAIN for Veterans Act has been reintroduced in the House! Thank you, @Rep. Greg Landsman, Rep. Derrick Van Orden, Congressman Chris Pappas, Rep. Jack Bergman, Rep. Terri Sewell, and Rep. Abraham Hamadeh, for your leadership on this lifesaving legislation!

Read the press release:


FOR IMMEDIATE RELEASE
July 17, 2025

MEDIA CONTACT
Alexa Helwig
alexa.helwig@mail.house.gov
(513) 235-9748

Landsman, Van Orden, Sewell, Bergman, Pappas, Hamadeh Introduce Bipartisan Bill to
Increase Veterans’ Access to Non-Opioid Medications
Cincinnati, OH – Today, Congressman Greg Landsman (D-OH-01), Congressman Derrick Van
Orden (R-WI-03), Congresswoman Terri Sewell (D-AL-07), Congressman Jack Bergman (R-MI-
01), Congressman Chris Pappas (D-NH-01), and Congressman Abraham Hamadeh (R-AZ-08)
introduced bipartisan legislation to increase veterans’ access to non-opioid pain medications.
The opioid epidemic has impacted nearly every demographic in the United States. In response,
Congress passed the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act in 2022 so
seniors on Medicare have access to and never pay more for non-opioid pain management
medications.
To ensure veterans have the same access, Congressman Landsman, Congressman Van
Orden, Congresswoman Sewell, Congressman Bergman, Congressman Pappas, and
Congressman Hamadeh have reintroduced the NOPAIN for Veterans Act – legislation that
would reform the way the Department of Veterans Affairs offers and covers non-opioid pain
management drugs.
The NOPAIN for Veterans Act would require the U.S. Department of Veterans Affairs to furnish
and cover non-opioid pain management drugs under VA pharmacy benefits if those drugs are
covered by Medicare.
Congressman Landsman:
“Our veterans deserve the very best care, which includes access to safer options for managing
pain. Our bipartisan bill is a commonsense step to make non-opioid treatments more affordable
and available to those who’ve served our country, and a way to prevent addiction before it
starts. We can protect our veteran’s health and keep pushing forward in the fight to end the
opioid epidemic.”
Congressman Van Orden:
“I thank the VA for taking the issue of opioid administration mismanagement seriously and the
great strides they have made over the years to improve care for our vets. Veterans must have
access to comprehensive medical treatment plans, and the NOPAIN for Veterans Act will
provide pain management alternatives that are safer, more effective, and promote long-term
recovery.”
Congresswoman Sewell:
“In 2022, Congress took a critical step in our fight against the opioid crisis by passing our
NOPAIN Act, providing better access to non-opioid pain medications for seniors. The NOPAIN
for Veterans Act builds on our progress, ensuring that such treatments are available to our
nation’s veterans as well. By increasing access to non-opioid therapies, we can empower more
Americans to effectively manage their pain without risking addiction.”
Congressman Bergman:
“Our Veterans deserve access to every effective treatment available - without red tape or delay.
The NOPAIN for Veterans Act ensures they get the care they’ve earned, especially when it
comes to managing chronic pain with safe, proven non-opioid alternatives. This is a critical step
toward improving quality of life while reducing dependence on addictive medications.”
Congressman Pappas:
“Veterans served and sacrificed for our country, and they shouldn’t face barriers to accessing
the medications and treatments they need and prefer. Making non-opioid pain management
more affordable and accessible to veterans is common sense for their health and for preventing
addiction. This bipartisan legislation will close the gap on VA’s non-opioid drug coverage to help
our veterans stay safe and healthy.”
Congressman Hamadeh:
“I am proud to cosponsor the NOPAIN for Veterans Act and am grateful to the sponsor for the
opportunity support an effort to protect my fellow Veterans with access to better healthcare
options. Far too many of our Veterans have fallen victim to the Opioid epidemic due to lack of
access to FDA-approved non-opioid alternatives. That is simply wrong. Our Veterans deserve
access to the full suite of non-addictive pain management options and so much more."
Tom Synan, Newtown Chief of Police and Board Member of Voices for Non-Opioid
Choices:
“As a police chief in Southwestern Ohio, we are on the front lines of the opioid addiction
epidemic. As a veteran myself, I know that veterans face additional risks for developing a
substance use disorder and prevention is critical for these individuals. This bill will go a long way
towards preventing addiction in our veteran community.”
The full text of the NOPAIN for Veterans Act can be found here.
###
landsman.house.gov

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 2

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 2

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 1

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 3

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 2

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 4

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 1

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming $100 Into Significant Wealth with MANH Stock

Updated Category News Views 175

Unlocking Wealth: The Manhattan Associates Investment Narrative Let’s dive into a real financial gem that’s often overshadowed by bigger names—Manhattan Associates (NASDAQ: MANH). This company isn’t just another name in the tech universe; it’s been killing it in the stock market arena with an annualized growth rate that clocks in at 18.87%. If you crunch those...

Continue Reading
Investors Alert: Class Action Opportunities with Law Offices

Updated Category News Views 176

Class Action Lawsuits Overview Investors are being reminded about important class action lawsuits related to several publicly-traded companies. These class actions provide shareholders an opportunity to seek justice for alleged securities fraud. The Law Offices of Howard G. Smith has initiated these lawsuits, urging affected investors to explore their legal options....

Continue Reading
Brink's Announces Earnings Call for Upcoming Financial Results

Updated Category News Views 136

Brink's Company Earnings Call Announcement RICHMOND, Va. — The Brink’s Company (NYSE: BCO), a premier global provider specializing in cash and valuables management, digital retail solutions, and ATM managed services, has announced that it will conduct a conference call to discuss the financial results from the second-quarter of the year. This event is slated for...

Continue Reading
Significant New Share Offering by DSV A/S Bolsters Financial Growth

Updated Category News Views 203

DSV A/S finalized a hefty equity offering that raised DKK 37.3 billion—about EUR 5 billion—in early 2024. They dropped a massive 26,444,523 new shares on the market to shore up their finances for the acquisition of Schenker AG from Deutsche Bahn. Traders were quick to gauge what this meant: a serious boost in their logistics game. Equity Offering Details: What's...

Continue Reading
AmacaThera Partners with Pacira BioSciences in Major Deal

Updated Category News Views 130

AmacaThera Develops Game-Changing Partnership with Pacira BioSciences AmacaThera has recently entered into a significant exclusive global licensing agreement with Pacira BioSciences, marking a pivotal moment for the innovative drug delivery company. This partnership is centered around AMT-143, AmacaThera's advanced long-acting non-opioid anesthetic designed for...

Continue Reading